OpenVSafe by OpenVAERS
Search V-safe

XZC-13443-29345

2 vaccinations 11 coded responses 13 check-ins 11 free-text entries 4 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
452 / OH
Registered
2021-06-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-24
    Registered in v-safe
  3. 2021-06-24
    Dose 2 — Pfizer-BioNTech
  4. 2021-06-24
    Health check-in — 0 day, dose 2
    Feeling: Fair · None · Be unable to work or attend school
    Adult check-in
  5. 2021-06-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Oropharyngeal pain — Feeling: Poor · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  6. 2021-06-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-06-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite — Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  8. 2021-06-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  9. 2021-06-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  10. 2021-07-01
    Survey response — 7 day, dose 2
    MedDRA: Fatigue, Infusion, Pre-existing disease — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  11. 2021-07-08
    Survey response — 14 day, dose 2
    MedDRA: Fatigue, Oropharyngeal pain, Peripheral swelling, Swelling face — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  12. 2021-07-15
    Survey response — 21 day, dose 2
    MedDRA: Medical counselling, Pain of skin, Peripheral swelling, Rash pruritic, Self-medication, Swelling face, Systemic lupus erythematosus rash — Feeling: Fair · Get care from a doctor or other healthcare professional
    MedDRA releases: 2021-09,2024-11 · check-in answers available
  13. 2021-07-15
    Report sent to call center — 21 day, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-07-23
    Survey response — 28 day, dose 2
    MedDRA: Fatigue, Feeling abnormal, Myalgia, Office visit, Pre-existing disease, Rash pruritic — Feeling: Poor · Be unable to work or attend school
    MedDRA releases: 2021-09,2024-11 · check-in answers available
  15. 2021-07-23
  16. 2021-08-05
    Survey response — 42 day, dose 2
    MedDRA: Fatigue, Muscle spasms, Myocardial infarction, Office visit — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional
    MedDRA releases: 2021-09,2024-11 · check-in answers available
  17. 2021-08-05
    Report sent to call center — 42 day, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-09-25
    Survey response — 3 month, dose 2
    MedDRA: Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11 · check-in answers available
  19. 2021-09-25
    Report sent to call center — 3 month, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  20. 2021-09-29
  21. 2022-06-24
    Survey response — 12 month, dose 2
    MedDRA: Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11 · check-in answers available
  22. 2022-06-24
    Report sent to call center — 12 month, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2022-06-27
  24. 2022-06-27
  25. 2022-06-27
  26. 2022-06-27
  27. 2022-06-27
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  28. 2022-06-27
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  29. 2022-06-27
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  30. 2022-06-27
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-06-03Pfizer-BioNTech No
22021-06-24Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-07-15 Successful
2022-06-27
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2021-08-05 Successful
2022-06-27
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2021-09-25 Successful
2022-06-27
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-06-24 Successful
2022-06-27
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 9

Systemic reaction (other): Lack of appetite, sore throat

Systemic reaction (other): Poor appetite

Systemic reaction (other): Runny nose

Systemic reaction (other): Runny Nose,

Systemic reaction (other): I am IgG defcient and get an infusion every 21 days. Today is my 12 hour infusion. It is common to feel run down before an infusion.

Symptoms: Swelling in face and hands. Sore throat. Fatigue

Symptoms: Rash that looked like Lupus appeared on my face. Very itchy. Used Benadryl cream and oral with no relief. Swelling of face and hands with skin sore to touch. 2 days later the rash peeled off with a wash cloth. Assume it was a subcutaneous staph
Healthcare visit (other): Message in MyChart

Symptoms: Itchy rash and muscle pain. Fatigue. I get an IgG infusion every 21 days and feel poorly prior to my infusion. Thursday was my infusion. I do not make immunoglobulin G. Saw my PCP on Wednesday. Unsure if I was recovering from Delta variant of COVID cut off by CDC

Symptoms: Miscle spasms and fatigue. My annual physical revealed I may had a minor myocardial infarction after my 2cd vaccination
Healthcare visit (other): Annual physical and EMG NCV testing ordered prior to vaccinations.

Symptoms: Lupus like rash. PCP thinks I have may have had the Delta variant of COVID

Release 12

Symptoms: Edema I am autoimmune immune deficient. Once Omicron came thorough last November I have had every variant. I get a central line infusion every 3 weeks of IgG and my Beta cells do not form correctly, so no vaccine has worked for about 20 years

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ · ✓
HCVOOffice visit ✓ · ✓
SDFatigue ✓ ✓ ✓
SDFeeling abnormal ✓ · ✓
SDMuscle spasms ✓ · ✓
SDMyalgia ✓ · ✓
SDMyocardial infarction ✓ · ✓
SDOffice visit ✓ · ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPain of skin ✓ · ✓
SDPeripheral swelling ✓ ✓ ✓
SDPre-existing disease ✓ · ✓
SDRash · · ✓
SDRash pruritic ✓ · ✓
SDSelf-medication ✓ · ✓
SDSwelling face ✓ ✓ ✓
SDSystemic lupus erythematosus rash ✓ · ✓
SRODecreased appetite ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROInfusion ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release